Web Analytics

3 Latest Announced Rounds

  • $2,600,000
    Pre-Seed

    3 Investors

    Software Development
    Jun 26th, 2025
  • $12,000,000
    Series A

    5 Investors

    Public Health
    Jun 26th, 2025
  • $15,000,000
    Series A

    6 Investors

    Software Development
    Jun 26th, 2025
$1,633.71M Raised in 40 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Artax Biopharma Inc

start up
United States - Cambridge, MA
  • 07/08/2024
  • Unknown
  • $8,000,000

Artax Biopharma is a development-stage biopharmaceutical company dedicated to the development of new therapies for autoimmune and inflammatory diseases. Artax Biopharma is developing the next generation of drugs targeting the interaction between TCR and Nck, which is responsible for T cell activation. Specific control over T cells through TCR, provides the compounds with the potential to become first-in-class immunomodulators for the treatment of a wide range of autoimmune and inflammatory diseases.


Related People

Rob ArmstrongFounder

Rob Armstrong United States - Greater Boston

N/A